Blog: INMED PHARMACEUTICALS INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) – Marketscreener.com

Item 7.01 Regulation FD Disclosure.

On June 14, 2022, the Company announced that a peer-reviewed scientific study
entitled “Effects of Rare Phytocannabinoids on the Endocannabinoid System of
Human Keratinocytes”has been published in the International Journal of Molecular
Sciences.

The information set forth in this Item 7.01, including Exhibits 99.1, is being
furnished and shall not be deemed “filed” for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise
subject to the liabilities of that section. The information set forth in this
Item 7.01, including Exhibit 99.1, shall not be deemed incorporated by reference
into any other filing under the Securities Act of 1933, as amended, or the
Exchange Act, except as shall be expressly set forth by specific reference in
such a filing.

Item 9.01. Financial Statements and Exhibits.



(d) Exhibits:


The following exhibits shall be deemed to be furnished, and not filed:



Exhibit No.   Description

99.1            News release, dated June 14, 2022
104           Cover Page Interactive Data File (embedded within the Inline XBRL
              document and included as Exhibit 101)




                                       1

© Edgar Online, source Glimpses

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s